Scleroderma and Pseudoscleroderma: Systemic Scleroderma, Morphea, and Allied Conditions
Philip C. Anderson
Abstract
Philip C. Anderson
Abstract
Obviously well-acquainted both with clinical scleroderma and with concepts about scleroderma, the authors have written a first-rate monograph which may need to be better advertised to reach the proper readers. The book is not an introduction to the subject. It is appropriate for the specialist, some residents, and a few well-supervised students, because unusual emphases and some modifications in terminology require careful interpretation if one also is to understand the Anglo-American literature. The authors do not hesitate to make generalizations or answer controversial questions, and their devotion to practical answers is commendable. The book opens with a concise review of pathogenesis, touching on each vague theory about hormones, infections, or allergy. The pertinent evidence for including scleroderma in a collagen disease group is reviewed and found inadequate. The unfamiliar European literature is summarized by subject and discussed with our familiar literature about scleroderma. The immunologic changes in the disease are
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Obviously well-acquainted both with clinical scleroderma and with concepts about scleroderma, the authors have written a first-rate monograph which may need to be better advertised to reach the proper readers. The book is not an introduction to the subject. It is appropriate for the specialist, some residents, and a few well-supervised students, because unusual emphases and some modifications in terminology require careful interpretation if one also is to understand the Anglo-American literature. The authors do not hesitate to make generalizations or answer controversial questions, and their devotion to practical answers is commendable. The book opens with a concise review of pathogenesis, touching on each vague theory about hormones, infections, or allergy. The pertinent evidence for including scleroderma in a collagen disease group is reviewed and found inadequate. The unfamiliar European literature is summarized by subject and discussed with our familiar literature about scleroderma. The immunologic changes in the disease are
Key concepts: Medicine, Morphea, Scleroderma (fungus), Systemic scleroderma, Dermatology, Systemic disease, Localized Scleroderma, Pathology